Table 2. Demographic characteristics of ALKBH4 expression in HCC.
| Characteristics | Total(N) | Odds Ratio (OR) | P value |
|---|---|---|---|
| T stage (T2&T3&T4 vs. T1) | 371 | 1.629 (1.082–2.460) | 0.020 |
| N stage (N1 vs. N0) | 258 | 2.773 (0.350–56.463) | 0.380 |
| M stage (M1 vs. M0) | 272 | 0.319 (0.016–2.525) | 0.325 |
| Pathologic stage (Stage II&Stage III&Stage IV vs. Stage I) | 350 | 1.513 (0.994–2.310) | 0.054 |
| Histologic grade (G2&G3&G4 vs. G1) | 369 | 1.578 (0.886–2.859) | 0.125 |
| Tumor status (With tumor vs. Tumor free) | 355 | 1.456 (0.955–2.224) | 0.081 |
| Age (>60 vs. <=60) | 373 | 1.125 (0.749–1.691) | 0.570 |
| Gender (Male vs. Female) | 374 | 1.187 (0.769–1.834) | 0.439 |
| Vascular invasion (No vs. Yes) | 318 | 0.960 (0.604–1.526) | 0.863 |
| Residual tumor (R1&R2 vs. R0) | 345 | 2.087 (0.791–6.119) | 0.151 |
| AFP (ng/ml) (>400 vs. <=400) | 280 | 1.548 (0.887–2.726) | 0.126 |
| Albumin(g/dl) (>=3.5 vs. <3.5) | 300 | 0.920 (0.536–1.578) | 0.760 |